Environmental chemicals in our bodies – we know they are in there, but what does it mean?

Judy S. LaKind, Ph.D., President of LaKind Associates, LLC, Adjunct Associate Professor, Department of Epidemiology and Public Health, University of Maryland School of Medicine and Adjunct Associate Professor, Department of Pediatrics, Pennsylvania State University College of Medicine, Milton S. Hershey Medical Center is a health and environmental scientist with expertise in strategic risk management, assessment of human exposure to environmental chemicals and associated risks, biomonitoring, and environmental regulatory review. You can find her webpage here.

Chemicals and disease in population surveys

In the US, the number of chemicals routinely measured in people’s bodies has grown rapidly – our powerful analytical capabilities now allow us to identify over 1,000 individual chemicals in a single blood sample. Unfortunately, however, our analytical capabilities have outpaced our ability to interpret these data.

The National Health and Nutrition Examination Study (NHANES), a national survey conducted every two years by the U.S. CDC to assess health status, monitors for the presence of over 200 different chemicals in blood and urine samples. Chemical data from NHANES surveys are useful for several important purposes, such as understanding whether exposure to a particular chemical is reduced following a ban on that chemical. Many scientists have also explored the NHANES data looking for links or associations between chemical exposure and various health conditions and diseases. However, it is important to recognize the limitations of such data: studies such as these are cross-sectional, meaning that people are examined only once, providing exposure data for only a snapshot in time rather than over the long-term. Read more

The Top Six Science Marketing Hits of 2012

Marc Kuchner is the author of Marketing for Scientists, an astrophysicist at NASA’s Goddard Space Flight Center and a country songwriter. He is the co-inventor of the band-limited coronagraph, a tool for finding planets around other stars that will be part of the James Webb Space Telescope. He is also known for his work on planets with exotic chemistries: ocean planets, helium planets, and carbon planets. Kuchner received his bachelor’s degree in physics from Harvard and his Ph.D. in astronomy from Caltech. He was awarded the 2009 SPIE early career achievement award for his work on planet hunting. He has contributed to more than 100 research papers and published articles in journals including the Astrophysical Journal, Nature, and Astrobiology. He appears as an expert commentator in the Emmy nominated National Geographic television show “Alien Earths” and frequently writes articles in Astronomy Magazine. For more career tips for scientists, go to www.marketingforscientists.com. You can also follow Marc on Twitter @marckuchner.

You’re cuddled up with your loved ones, recounting your favorite moments of the year. To amplify your joy, let me share with you this list of my six top science marketing successes of 2012, compiled with help from the Marketing for Scientists Facebook group. Click here to compare them with last year’s top five list.

It was a good year for us with celebrities like pop singer Bjork’s sticking up for science, the continued success of television’s Big Bang Theory, and rappers, hipsters and pop stars around the world sporting dark plastic glasses. But these events below combined marketing techniques with the substance of science, educating us even as they drew us in. Read more

Planet of the Apps: Social Media, Outreach, and your Research

Gwen Pearson is Network Manager for the Organization of Biological Field Stations, and an online strategy consultant for nature centers and researchers.  She formerly was Asst. Director for Education and Outreach at Kellogg Biological Station.

When I talk to Field Station Managers or Researchers about promoting their work with social media, the first thing they say is, “Oh great, MORE stuff I have to do.”

Certainly, social media can be overwhelming; there are thousands of choices about ways to create content, engage the community, and advertise your research and outreach programs.  Unfortunately, print isn’t dead yet, nor is email.  There are a lot of rumors about email’s demise, but about 92% of online adults use email; 61% use it daily. Just because you are online and being social, that doesn’t mean you can stop doing all the other things you are doing.

The world of social media is just like the print and email worlds: billions of messages are competing for attention.   How do you break through all that competition, and get the attention of the public? How can you mobilize and engage people to create a community of supporters (and possibly donors)?

Before you start picking out your Facebook cover photo, stop and assess what you are doing already in terms of your communication efforts. Read more

Supporting tomorrow’s leaders today

Professor David Adams’ clinical interests are transplant hepatology and autoimmune liver disease. Laboratory research interests are focused on mechanisms of immune-mediated liver disease. After initial training in hepatology in Birmingham he continued his immunology training at the Experimental Immunology Branch of the National Cancer Institute, Bethesda, USA, before being appointed to the Chair of Hepatology in Birmingham in 1997. He served on the scientific committee and governing board of the European Association for Study of the Liver between 2004-2007 and currently sits on its Ethics committee. He was a councillor for the European Society for Organ Transplantation between 2004-2008. He was made a Fellow of the Academy of Medical Sciences in 2000, sits on the Academy’s Council and Chairs the Academy’s Mentoring Advisory Group.

You can follow the Academy of Medical Sciences mentoring team on Twitter – search for @AMSMentoring.

Mentoring has a vital role to play in developing the next generation of medical researchers, enabling them to fulfill their potential and make the most of the outstanding opportunities the UK affords for medical research.

A clinical academic’s career path, whilst potentially hugely rewarding, also presents significant challenges. There are numerous decisions to be made which can have major impacts on the individual’s long term career trajectory. Medical researchers, whether clinically trained or not, have always benefited from informal advice and encouragement from peers and senior colleagues. This advice – whether it’s a chance conversation with a colleague in a departmental common room, discussion with attendees at a conference or through a phone call to a former supervisor – can be instrumental in developing and shaping the direction of an academic career.

However, although informal advice is great, it is easily tinged with personal preferences and I believe there is a need for formal mentoring. There is increasing evidence that formal mentoring is helping to produce a generation of researchers who are more confident in their own abilities, and who value and draw on diverse personal support networks. It also develops in individuals the ability to ask the right questions, challenge assumptions and explore options. I believe that the establishment of formal mentoring schemes is starting to create a ‘mentoring culture’ in which researchers receive high quality mentoring and support as well as the informal advice of peers and colleagues which has always been available.

My first experience of a formal mentoring scheme came through the Academy of Medical Sciences. The Academy’s mentoring scheme provides an excellent model of best practice in this area. Funded by NIHR and the devolved administrations, the scheme is open to postdoctoral clinical academic trainees throughout theUK, specifically Clinical Lecturers and Clinician Scientist Fellows. Mentors are drawn from the Academy’s 1000-strong Fellowship. Mentors and mentees are encouraged to develop their mentoring skills through workshops with dedicated Academy staff available to answer questions about mentoring and to administer the pairing process. I am both a mentor on the Academy’s scheme and also chair a group which assists the Academy in developing the scheme.

As well as providing high quality mentoring to a specific cohort of clinical academic trainees, the Academy’s scheme is seeding mentoring in other institutions. Professor Charles Pusey FMedSci at Imperial College London started a mentoring scheme for Imperial’s Academic Clinical Fellows, clinical PhD students and Clinical Lecturers based on the Academy’s scheme. This scheme is now an integral part of postgraduate medical training at Imperial. Career development support is clearly valuable at every stage of training. I’m delighted that Imperial have taken our model and adapted it to support all their trainees.

Our scheme has developed a lot over the past 10 years and the Academy has collated some principles we’ve learned the hard way into a booklet and a series of short films, which we hope will be useful to others looking to support young researchers. As well as Imperial, other groups and organisations are already learning from the Academy’s experiences and designing their own support schemes.

One size certainly doesn’t fit all and a great example of a tailored scheme is the establishment of a forum for dental academic trainees which was launched at a NIHR event this year. This is part mentoring scheme and part peer support network – tailored to fit the needs of this diverse group. The forum includes a large group of dentists at every stage of academic training. They are planning to meet regularly and connect via LinkedIn during the interim periods. The group aims to provide the benefits of informal mentoring (a diverse network of willing advisors and a chance for one-off mentoring conversations to happen) without the administrative burden of a more formal scheme.

The Academy’s mentoring scheme continues to develop and our staff are always happy to speak about it, or to give advice about mentoring in general. If you are eligible for an Academy mentor I strongly encourage you to take advantage of this excellent opportunity. For my part, aside from my involvement in the Academy’s scheme, I’m trying to set up mentoring within my clinical specialty, as Chair of the British Society of Gastroenterology’s Academic Advisory Committee. How are you contributing to a mentoring culture?


Effective Strategies for Personalized Cancer Therapy Lessons from the 2012 US Presidential Elections

Sandeep C. Pingle has a PhD in Pharmacology and is a clinically trained physician. He is currently working as a postdoctoral scholar at Moores Cancer Center, UC San Diego. His research focuses on signaling pathways in cancer and treatment-associated neurotoxicity. In addition, Sandeep is San Diego Editor for the blog Roundtable Review by Oxbridge Biotech Roundtable. You can follow him on Twitter.

The 2012 election season in the US that ended a few weeks ago witnessed a never-before-seen barrage of “targeted” television advertisements, phone calls and door knocks. The use of “big data” by campaigns to effectively micro-target voter groups was particularly striking. Data companies gathered over 500 attributes from individual records including voting histories, demographics, hobbies, income etc. These data points were plugged into sophisticated algorithms on computer models to generate scores that identified undecided voters most likely to “swing”. The “persuasion scores” thus obtained drove campaign strategies to target these swing voters. Research shows that such voter targeting likely yields huge successes in terms of persuading unconvinced voters. Another layer to political campaigning was the use of transactional data to evaluate how opinions would change after interactions with campaign volunteers. Together, big data and an efficient use of technology have radically changed the nature of campaigning. It is remarkable how similar this approach is to that of personalized cancer medicine. Or at least to how an ideal personalized medicine approach should be for cancer management. Read more

A Review of Peer Review

Josh Salvi is a biomedical fellow in the Laboratory of Sensory Neuroscience at The Rockefeller University and a student in the Tri-Institutional MD-PhD Program. He also acts as Executive Director of the Weill Cornell Community Clinic. You can read more of his posts on his blog, Musings of a MudPhud and can follow him on Twitter (@joshsalvi).

A key component in science is communication. We hope that this communication is accurate, conveys its intended purpose, and remains archived for future reference. Thus, the medium by which this message is conveyed must be regulated.

Peer review is the process by which members of a field evaluate the work of other members in the same field as a form of regulation. This increases credibility and, presumably, quality within the field. For example, this can refer to review of manuscripts for publication, review of teaching methods by other educators, or, within the medical profession, the creation and maintenance of health care standards. My focus will be on scholarly peer review, more particularly on methods of peer review in publication and less in the clinical setting for the purposes of this post. Issues relating to technical peer review in fields such as engineering or standardization within education will not be discussed here. However, remember that “peer review” is a broad term encompassing many fields. The purpose of this post is to bring to light historical context and to bring into focus the benefits and drawbacks of our current system.

In 1665, Henry Oldenburg created the first scientific journal to undergo peer review, the Philosophical Transactions of the Royal Society. Peer review in this journal differed from the kind we see today. Whereas professionals in the same field and often in competing labs will review today’s articles for publication, articles in this journal were reviewed by the Council of the Society. This journal created a foundation for the papers we see today, disseminating peer-reviewed work and archiving it for later reference. Peer review later developed in the 18th century as one where other professionals, often experts in the field, would perform the review, as opposed to the editorial review of the aforementioned journal. This form of scholarly peer review did not become institutionalized until closer to the 20th century. However, professional peer review, such as that performed by physicians, dated back to the 9th and 10th centuries, where one physician would comment on the ethical decisions or procedures of another.

Since that time, scholarly peer review has become a mainstay of academic publication. It is amazing to think that this regulatory process has only been so strong for less than a century. However, the procedure does not come without significant criticism (Though what topic in science is not heavily criticized?).

First, though, let us consider the benefits of scholarly peer review. Mentioned above was the improved quality of published work. Simply put, this works by first presenting a barrier that authors must overcome in order to be published, and critiques from reviewers are then addressed by authors to improve the quality of a manuscript. These suggestions may include additional experiments that will further test the work. The process filters out scientific error, thus improving accuracy of published information. Poor-quality work is rejected by the peer-review process. Additionally, work is stratified by journal quality, and this process routes papers to the correct tier. In effect, peer review is at the heart of scientific critique.

One of the most common critiques of peer review is that it remains untested, as purported by a 2002 article in JAMA. The Cochrane Collaboration in 2003 (and reconfirmed in 2008) concluded that there existed “little empirical evidence to support the use of editorial peer review as a mechanism to ensure quality of biomedical research, despite its widespread use and costs.” They recommend, “A large, well-funded programme of research on the effects of editorial peer review should be urgently launched.” Additionally, a study took an article about to be published in the British Medical Journal (BMJ), purposely added a number of errors, and measured the error detection rate to be about 25%, with no reviewer correcting more than 65% of the errors. This study was particularly interesting, as it was headed by Dr. Fiona Godlee, who later went on to critique the lack of external peer review of the Cochrane Collaboration. Her pioneering work in this field has stimulated much interest.

Finally, single-blinded peer review is open to bias. This could be bias against nationality, language, specialty, gender, or competition. Additionally, there is a common trend of bias toward positive results. Double-blinded review may help to overcome this critique.

Alternatives to single-blind review include double-blind review, post-publication review, and open review. In double-blind review, neither the authors nor the reviewers know the other party, and this would presumably reduce aforementioned bias. Surveys had shown a preference to double-blind review. Post-publication review would be an excellent supplement to the current review system to improve the rate of error correction in publications. Finally, open peer review, where the reviewer is known, would also possibly reduce the bias. However, one may be less willing to critique work by a senior author in the field, and the pilot by Nature in 2006 was far from successful.

The question is not, “Is peer review an ineffective system?” I believe it is. Instead, the question is, “Why does peer review sometimes fail to meet our lofty expectations?” This is a question that can be answered with rigor.

At this stage, the system is the best we have, and problems lie less in the peer review process and more in the access to scholarly work without a costly subscription. Discontent in the field does not translate to a desire for one of the alternative methods described. Nonetheless, we should be critical of our process, much in the same way the process itself is critical.

Socially Contagious Itching

Jamie Ward is a Professor of Cognitive Neuroscience at the University of Sussex. You can find his webpage here and he is @jamiewardsussex on Twitter.

If you see someone having a vigorous scratch then does this make you feel itchy too?  There have been many anecdotes to suggest that observations or thoughts of itchiness make people feel itchy themselves.  For instance, it can be quite hard for medical students to sit through dermatology classes without engaging in scratching at some point!  However a new study published in PNAS this month explores this systematically for the first time and provides the first evidence for the neural basis of socially contagious itch.  It also considers why some people may be more prone to it than others.

The study used movie clips of people scratching their arm or chest for 20 seconds.  One of the first challenges for designing this study was to find control stimuli that were approximately matched to these stimuli but would not induce feelings of itchiness.  Our pilot research led us to use movies of tapping of the same body parts: this involves both observation of touch, and observations of self-generated actions, but without any connotations of itchiness.  The study itself involved presenting these two sets of stimuli to two groups of participants.  At the end of each movie they were simply asked to rate how itchy it made them feel.  One group of participants observed the movies whilst undergoing fMRI (functional magnetic resonance imaging) scanning.  Another group  took the test in the lab and we recorded any spontaneous scratching actions.  (The imaging group were not allowed to scratch).  The movies depicting scratching tended to elicit itchiness in virtually all participants and around two-thirds of participants scratched themselves at some point in this condition (when free to do so). Read more

Curious about life on Mars – Curiosity has the answers!

Dr Louisa J. Preston is a Postdoctoral Research Associate at The Open University. Louisa is a TED fellow and tweets @LouisaJPreston.

A robotic planetary geologist landed on Mars at 6.31am GMT on Monday August 6th 2012. The appropriately named ‘Curiosity’ rover is NASA’s latest offering to help us determine whether past and/or present habitable environments exist on Mars. This car-sized, nuclear-powered mobile science laboratory is on a mission to Gale Crater, a 154 km diameter impact crater located just south of the equator. Here, scientists are hoping to learn about the environmental conditions that existed in the crater and whether these conditions would have favoured life.

Within minutes of being lowered onto the dusty surface, Curiosity transmitted back images of a beautiful sun drenched Martian vista. Since then hundreds of images have been returned to Earth, but none as breath-taking as Curiosity’s self-portrait captured by the Mars Hand Lens Imager (MAHLI). It was taken on Sol 84 and shows the rover, scoop marks, tire tracks and Mount Sharp rising in the background. Although I am not a member of the MSL team, like hundreds of scientists around the world, I am following the progress of the mission, eagerly awaiting the data Curiosity is collecting. I guess you could say we are Curiosity groupies.

The rover at "Rocknest” in Gale Crater. This full colour image is composed of a set of 55 high-resolution images stitched together

NASA/JPL-Caltech/Malin Space Science Systems

Of the ten science instruments on board, the Sample Analysis at Mars (SAM) package is a particular focus of mine. It is a suite of three analytical tools designed to study chemistry relevant to life by checking for carbon-based compounds which on Earth are used as life’s molecular building blocks. Results from SAM are already coming in and will ultimately change how we view Mars by providing us with definitive evidence regarding its habitability potential. A positive result i.e. the discovery of organic compounds, will not necessarily mean there is life on Mars, just that conditions have existed at this site that might have allowed for it.

One major factor in whether Mars was ever habitable is the composition of its atmosphere, how this composition has changed over billions of years and ultimately what caused Mars to lose a large fraction of it. The first ‘sniffs’ of the Martian atmosphere by SAM have catalogued the most sensitive measurements to date. Initial results of atmospheric CO2 show an increase of 5% in heavier isotopes of carbon compared to estimates of the isotopic ratios present when Mars formed. These enriched ratios of heavier isotopes to lighter ones suggest the top of the atmosphere may have been lost to interplanetary space. This provides weight to theories that in Mars’ distant past it may have had a thicker atmosphere and liquid water on its surface. NASA’s Mars Atmosphere and Volatile Evolution (MAVEN) mission will investigate this question of atmospheric loss further when it arrives at Mars in 2014. Its main goal is to search for methane gas, a simple precursor chemical for life. SAM’s atmospheric measurements, however, so far reveal little to no methane. This gas is of interest as, on Earth, it is one of the most abundant organic compounds and can be produced biologically or by non-biological processes. If this isn’t enough work for SAM, it is also set to analyse its first solid sample in the coming weeks, beginning the search for organic compounds in the rocks and soils of Gale Crater. This will answer the question of whether Gale Crater was once, or possibly is currently, a habitable environment.

Another instrument making headlines is the Chemistry and Mineralogy (CheMin) experiment which provided the first analysis of Martian soil from within Gale Crater. Crystalline feldspar, pyroxenes and olivine mixed with some amorphous (non-crystalline) material was identified and this is similar to volcanic soils in Hawaii. Hawaii has long been considered a brilliant analogue environment for Mars, with this latest finding highlighting the relevance of planetary analogue research and opening the world’s eyes to the fact that, although the Earth and Mars may look very different, there are actually many similarities. I work in environments such as Hawaii, which is almost like visiting another planet in the study of the rocks, soils and life that thrive there. Some of these sites, such as Antarctica, are a little hard to get to, whereas others include the red acidic rivers of Rio Tinto in Spain, the volcanoes of Mt Teide in Tenerife and Mt Etna in Italy, hot springs in Iceland and Yellowstone National Park, and the hundreds of impact craters around the world, such as those in the Canadian High Arctic and Arizona. Looking at these places teaches us about the possibilities of life in similar environments and geological settings on Mars, what this life might look like and what tools and technologies we might need to find it.

The base of Mount Sharp

NASA/JPL-Caltech/MSSS

 

Mars Desert Research Station in the canyon lands of Utah, a Mars analogue site

Image from http://mdrs.marssociety.org/

 

 

 

 

 

 

 

This search for life on Mars is the cornerstone of Astrobiology, which is an enigma amongst science as it has yet to prove its subject matter actually exists i.e. we have not found extra-terrestrial life. This multi-disciplinary subject, however, is growing at an immense rate and now involves diverse fields such as geology, biology, chemistry, physics, history and medicine to name a few, all working together to answer humanity’s last great question – is there life beyond the Earth?

Fomalhaut b: the Phoenix Planet

Dr. Thayne Currie is currently a postdoctoral fellow in the Department of Astronomy and Astrophysics at the University of Toronto. His research focuses on detecting and characterizing massive planets via direct imaging. The main goals of his research are to understand the formation and evolution of planetary systems, to determine how the solar system fits within the range of planet formation outcomes and how the properties of planets around other stars compare to those in our solar system.

 

In November 2008, two teams announced what were then described as the first directly imaged exoplanetsplanets outside a Solar System, around stars HR 8799 and Fomalhaut. The object called Fomalhaut b (reported by Kalas et al. 2008) was imaged just inside the debris ring and was invoked to explain the ring’s offset from the star. From comparing the ring’s thickness and location to models for ring sculpting by planets, the authors concluded that Fomalhaut b is likely jovian mass. They found Fomalhaut b to be variable, a feature they attribute to gas accretion onto the planet. Read more

Playing Dumb – Does being in a group setting affect your IQ?

Marcia Malory began her academic career as a chemistry student but ended up receiving a Bachelor of Arts in Political Science from Brooklyn College of the City University of New York. Since then, she has worked in various industries in the United States and the United Kingdom. She is interested in how science, culture and politics interact.  Visit her website or follow her on Twitter @sciencefindout.  

Do you ever downplay your intelligence when you are around others? Recently, an experiment was performed to determine how being in a group setting affects IQ test results. University students took pencil and paper IQ tests to determine their baseline IQ scores. They were not told their results.

Afterwards, the subjects had to take another IQ test – a multiple-choice exam given on a computer. Subjects were divided into groups of five. After answering a question, each was told how she or he ranked compared with the other four members of the group and the relative rank of one other group member. The researchers focused on subjects who had scored about the same on the baseline IQ test; they had a mean IQ of 126.

Although all of the subjects had similar baseline IQs, the results on the computer test varied widely. The IQs of some subjects stayed about the same, but the IQs of other subjects dropped dramatically. The researchers divided the test takers into two groups – “high performers”, who scored above the new median, and “low performers”, who scored below that median. The IQs of the low performers dropped by an average of 17.4 points. Read more